BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6182091)

  • 1. HLA-linked lymphocyte activating determinants.
    Termijtelen A; van Leeuwen A; van Rood JJ
    Immunol Rev; 1982; 66():79-101. PubMed ID: 6182091
    [No Abstract]   [Full Text] [Related]  

  • 2. Typing for human alloantigens with the primed lymphocyte typing technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Adv Immunol; 1982; 32():65-156. PubMed ID: 6180612
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants.
    Pollack MS; Chin-Louie J; Callaway C; Blanco MA; Slavin K; Sullivan K; O'Reilly RJ; Dupont B
    J Clin Immunol; 1983 Oct; 3(4):341-51. PubMed ID: 6197424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigens: structure, separation of subpopulations, gene cloning and function.
    Shackelford DA; Kaufman JF; Korman AJ; Strominger JL
    Immunol Rev; 1982; 66():133-87. PubMed ID: 6813244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic organization and polymorphism of the HLA-D region].
    Guilherme L; Colombani M; Sansonetti N; Colombani J
    Ann Immunol (Paris); 1983; 134C(1):3-24. PubMed ID: 6190429
    [No Abstract]   [Full Text] [Related]  

  • 6. The HLA system and its relation to disease.
    McDevitt HO
    Hosp Pract (Off Ed); 1985 Jul; 20(7):57-72. PubMed ID: 3159741
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-D region molecules restrict proliferative T cell responses to antigen.
    Thorsby E; Berle E; Nousiainen H
    Immunol Rev; 1982; 66():39-56. PubMed ID: 6182089
    [No Abstract]   [Full Text] [Related]  

  • 8. [HLA-D/DR-locus: its structure, function and role in infectious diseases].
    Pospelov LE
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):14-20. PubMed ID: 6084376
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenetic analysis of the HLA complex with alloreactive T cell clones.
    Duquesnoy RJ; Zeevi A
    Hum Immunol; 1983 Sep; 8(1):17-23. PubMed ID: 6226628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
    Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
    Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The human major histocompatibility complex or HLA complex].
    Lemonnier FA
    Biochimie; 1985 Jan; 67(1):XI-XV. PubMed ID: 2581625
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of HLA-DR with relevance to renal transplantation.
    Morris PJ; Ting A
    Immunol Rev; 1982; 66():103-31. PubMed ID: 6182088
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants not correlated with HLA-Dw, DR, or SB detected by primed lymphocyte typing.
    Segall M; Reinsmoen NL; Iwaki J; Bach FH
    Hum Immunol; 1982 Jun; 4(3):239-48. PubMed ID: 6181033
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.
    Shaut DM; Ireland J; Scornik JC; Peck AB
    Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity and HLA.
    Carpenter CB
    J Clin Immunol; 1982 Jul; 2(3):157-65. PubMed ID: 6811606
    [No Abstract]   [Full Text] [Related]  

  • 19. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions.
    Fainboim L; Jaraquemada D; Festenstein H; Sachs JA
    Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants].
    Wollman EE; Lepage V; Delima M; Fradelizi D; Degos L; Dausset J
    C R Seances Acad Sci D; 1980 Nov; 291(9):757-61. PubMed ID: 6162584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.